Wednesday, July 30, 2025 2:27:15 PM
Just an FYI. Dr Chertow at Stanford is an advisor to UNCY .
He's also the lead investigator for an acute kidney injury trial ...co is ICU .
Dr Chertow is considered one of the countries top experts ..KOL .. on kidney disease ...especially in the area of dialysis and dialysis patients ...and one of the reasons I'm in UNCY
Poster Ernie alerted me to ICU several weeks ago and originally I was dismissive .
However recent up dates from their pediatric trial and some more funding ...and a lot more DD ...has changed my view .
Co has a DSMB ( data safety ) review scheduled this Qt .
They will decide if ICU's pivotal trial should continue .
If it doesn't...Co is toast
I think the trial will continue and initiated a position this am .
H/T to Ernie for finding ICU
JMO
Not investment advice
Kiwi
He's also the lead investigator for an acute kidney injury trial ...co is ICU .
Dr Chertow is considered one of the countries top experts ..KOL .. on kidney disease ...especially in the area of dialysis and dialysis patients ...and one of the reasons I'm in UNCY
Poster Ernie alerted me to ICU several weeks ago and originally I was dismissive .
However recent up dates from their pediatric trial and some more funding ...and a lot more DD ...has changed my view .
Co has a DSMB ( data safety ) review scheduled this Qt .
They will decide if ICU's pivotal trial should continue .
If it doesn't...Co is toast
I think the trial will continue and initiated a position this am .
H/T to Ernie for finding ICU
JMO
Not investment advice
Kiwi
Recent UNCY News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:30:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:30:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 08:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 11:51:50 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 10:30:46 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/30/2026 11:04:02 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/30/2026 11:02:10 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 11:00:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/06/2026 01:11:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 11:29:20 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 10:32:02 AM
- Unicycive shares gain as FDA accepts resubmitted OLC NDA • IH Market News • 01/29/2026 03:01:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:14 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/14/2025 10:09:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 02:12:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:39:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2025 11:30:13 AM
- UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit • PR Newswire (US) • 10/14/2025 06:55:00 AM
